上肢机器人康复改善卒中后上肢功能:系统综述与Meta分析
该系统综述与Meta分析纳入54项随机对照试验、2744例卒中患者,比较剂量匹配的机器人康复与常规康复。机器人康复对上肢能力有统计学显著但幅度很小的改善(SMD 0.14),随访未维持,日常生活活动能力无显著差异。亚组分析提示设备辅助方式、活动关节、自由度、设备偏侧性和设备数量显著影响疗效。
要点
- 机器人康复对上肢能力的改善幅度很小(SMD 0.14),未达临床意义。
- 日常生活活动能力在治疗后及随访均无显著改善。
- 设备辅助方式、活动关节、自由度、偏侧性和设备数量显著影响疗效。
核心结论
- 机器人康复未在上肢能力或日常生活活动能力方面产生临床意义的改善。
- 亚组分析发现特定设备特征和干预参数显著影响机器人康复疗效,为设计实施提供指导。
研究设计与样本
- 检索6个电子数据库的随机对照试验,比较剂量匹配的机器人康复与常规康复。
- 纳入54项研究、2744例参与者,测量上肢活动水平变化。
- 采用随机效应模型(I2 ≥ 50%)或固定效应模型(I2 < 50%)评估疗效。
- 对机器人设备特征和干预参数进行系统分类,以进行亚组分析和Meta回归。
主要发现
- 机器人康复对上肢能力有小的统计学显著正效应(SMD 0.14,95% CI [0.02, 0.26])。
- 随访时上肢能力改善未维持(SMD 0.05,95% CI [-0.13, 0.24])。
- 日常生活活动能力在治疗后无显著差异(SMD 0.04,95% CI [-0.05, 0.13])。
- 日常生活活动能力在随访时无显著差异(SMD 0.05,95% CI [-0.13, 0.24])。
- 亚组分析显示设备辅助方式(p = 0.0046)、活动关节(p = 0.0133)、自由度(p = 0.012)、设备偏侧性(p = 0.0048)和设备数量(p = 0.0001)对疗效有显著影响。
关键数值与推荐
- 纳入标准为比较剂量匹配的机器人康复与常规康复的随机对照试验,测量上肢活动水平变化。
- 机器人康复对上肢能力的效应量为SMD 0.14(95% CI [0.02, 0.26])。
- 随访时上肢能力的效应量为SMD 0.05(95% CI [-0.13, 0.24])。
- 治疗后日常生活活动能力的效应量为SMD 0.04(95% CI [-0.05, 0.13])。
- 随访时日常生活活动能力的效应量为SMD 0.05(95% CI [-0.13, 0.24])。
临床怎么用
- 机器人康复对上肢能力的改善幅度小且不维持,日常生活活动能力无显著获益。
- 选择设备时需考虑辅助方式、活动关节、自由度、偏侧性和设备数量对疗效的影响。
局限性
- 上肢能力改善未在随访中维持,远期疗效不确定。
- 未发现对日常生活活动能力的显著改善,功能转移证据不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following stroke, upper limb impairment is common and frequently limits ability to perform everyday activities. Due to limited resources, current therapy levels are insufficient to optimise functional improvement. Robotic devices have potential to augment upper limb stroke rehabilitation, but knowledge regarding the optimal device features and intervention parameters is limited. This systematic review and meta-analysis aimed to determine the efficacy of upper limb robotic rehabilitation compared with conventional rehabilitation, and to critically explore the device features and programme parameters that influence rehabilitation outcomes. METHODS: Six electronic databases were searched for RCTs that compared dose-matched robotic versus conventional rehabilitation following stroke, and measured activity level changes in upper limb outcomes. The efficacy of robotic compared with conventional rehabilitation was evaluated using random-effects (I2 ≥ 50%) or fixed-effect (I2 < 50%) models. A systematic categorization of robotic device features and intervention parameters was conducted to facilitate subgroup analyses and meta-regression, enabling exploration of how these factors influence rehabilitation outcomes. RESULTS: The review included 54 studies, involving 2744 participants. Meta-analysis demonstrated that robotic rehabilitation had a small, statistically significant positive effect on upper limb capacity compared with conventional rehabilitation (SMD 0.14, 95% CI [0.02, 0.26]), however these gains were not maintained at follow-up (SMD 0.05, 95% CI [- 0.13, 0.24]). No significant differences were found between robotic and conventional rehabilitation for ADL outcomes either post-treatment (SMD 0.04, 95% CI [- 0.05, 0.13]) or at follow-up (SMD 0.05, 95% CI [- 0.13, 0.24]). Subgroup analyses provided crucial insights into the factors influencing robotic rehabilitation efficacy, revealing significant effects of device assistance (p = 0.0046), joints mobilized (p = 0.0133), degrees of freedom (p = 0.012), device laterality (p = 0.0048), and the number of devices used (p = 0.0001). CONCLUSIONS: The results suggest that robotic rehabilitation does not result in clinically meaningful improvement in either upper limb capacity or ADL performance. However, this study's novel subgroup analyses highlight specific device features and intervention parameters that significantly influence efficacy. These findings provide critical guidance for the design, implementation, and future research of robotic rehabilitation.
引用
- Boardsworth K, Rashid U, Olsen S, et al. Upper limb robotic rehabilitation following stroke: a systematic review and meta-analysis investigating efficacy and the influence of device features and program parameters. J Neuroeng Rehabil. 2025. PMID: 40671078. doi:10.1186/s12984-025-01662-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。